1-99916470-TA-TAAA
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000642.3(AGL):c.4322_4323dupAA(p.Gly1442LysfsTer28) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,382 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G1442G) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000642.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- glycogen storage disease IIIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Laboratory for Molecular Medicine, Myriad Women’s Health, Orphanet, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AGL | NM_000642.3 | c.4322_4323dupAA | p.Gly1442LysfsTer28 | frameshift_variant | Exon 32 of 34 | ENST00000361915.8 | NP_000633.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AGL | ENST00000361915.8 | c.4322_4323dupAA | p.Gly1442LysfsTer28 | frameshift_variant | Exon 32 of 34 | 1 | NM_000642.3 | ENSP00000355106.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250644 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460382Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726462 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Glycogen storage disease type III Pathogenic:4
This sequence change creates a premature translational stop signal (p.Gly1442Lysfs*28) in the AGL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AGL are known to be pathogenic (PMID: 19299494). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with glycogen storage disease III (PMID: 28888851, 31661040). This variant is also known as c.4323_4324insAA. ClinVar contains an entry for this variant (Variation ID: 371085). For these reasons, this variant has been classified as Pathogenic. -
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Variant summary: AGL c.4322_4323dupAA (p.Gly1442LysfsX28) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 250644 control chromosomes (gnomAD). c.4322_4323dupAA has been reported in the literature in individuals affected with Glycogen Storage Disease Type III (examples: Laforet_2019 and Decostre_2017). These data indicate that the variant is likely to be associated with disease. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1
The c.4322_4323dupAA pathogenic variant in the AGL gene has been reported previously using alternate nomenclature (c.4323_4324insAA or c.4724insAA), either in the homozygous state or in combination with another AGL variant, in several individuals with a diagnosis of glycogen storage disease type III confirmed by enzyme analysis (Decostre et al., 2016; Lucchiari et al., 2002). The c.4322_4323dupAA variant causes a frameshift starting with codon Glycine 1442, changes this amino acid to a Lysine residue, and creates a premature Stop codon at position 28 of the new reading frame, denoted p.Gly1442LysfsX28. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.4322_4323dupAA variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.4322_4323dupAA as a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at